I enjoy listening to the sounds of the city outside my bedroom window at night. Cars hum down the thoroughfare where I live, their headlights…
Fatty liver disease
FATTY LIVER DISEASE
NewsFDA weighs noninvasive biopsy alternative in MASH clinical trials
The U.S. Food and Drug Administration (FDA) will evaluate the use of Fibroscan, a noninvasive test, to replace liver biopsies in clinical trials for metabolic…
FATTY LIVER DISEASE
ColumnsTaking care of our teeth is crucial with liver disease
For as long as I can remember, I’ve dreaded visiting the dentist. It started in childhood with a mean dentist who’d once had his thumb…
FATTY LIVER DISEASE
NewsAlcohol consumption disrupts protein that controls liver fat: Study
Exposure to excessive alcohol disrupts the activity of a protein that plays a key role in keeping liver fat healthy, a study found. Researchers said…
FATTY LIVER DISEASE
ColumnsWith liver disease, getting a good night’s sleep is crucial
I have mixed feelings as summer begins to pack up shop for the year. This season has a certain energy, like a house party with…
FATTY LIVER DISEASE
ColumnsMASH motivates me to help my family make healthy choices
My daughter has never asked much about my health, let alone how I live with metabolic dysfunction-associated steatohepatitis (MASH). I don’t expect her to…
FATTY LIVER DISEASE
NewsDrug for fatty liver disease MASH may help prevent transplants
Regulators in the European Union (EU) have granted conditional approval to Rezdiffra (resmetirom) for some people with metabolic dysfunction-associated steatohepatitis (MASH), making it the first…
FATTY LIVER DISEASE
NewsFDA gives conditional approval to Wegovy for some liver patients
The U.S. Food and Drug Administration (FDA) has conditionally approved Novo Nordisk’s Wegovy (semaglutide) to treat certain people with metabolic dysfunction-associated steatohepatitis (MASH), a…
FATTY LIVER DISEASE
ColumnsWhy ‘Dr. Google’ is a poor substitute for my liver doctor
Having a chronic disease like my metabolic dysfunction-associated steatohepatitis (MASH) can play tricks on not just your body, but also your mind. Case in…
FATTY LIVER DISEASE
NewsNorUDCA becomes first MASLD therapy approved in India
India’s Central Drugs Standard Control Organization has approved the oral therapy nor-ursodeoxycholic acid (NorUDCA) for people with metabolic dysfunction-associated steatotic liver disease (MASLD), a form…
Recent Posts
- First reported case links Alagille syndrome with biliary atresia
- FDA OKs linerixibat, now Lynavoy, as first US treatment for itch in PBC
- $24M US grant to back global team working toward hepatitis B cure
- MRI biomarker may predict PSC liver complications: Study
- Vitamins play a key role in liver health, so monitoring your levels is crucial